Carl Schanbacher is a Dermatology physician affiliated with Tufts University. OpenAlex indexes 53 publications with 1,689 citations (h-index 15); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
340 Maple St
Suite 203
Marlborough, MA 017523200
Telephone
508-485-7779Registry record last updated 19 Dec 2013.
Clinical trials
- Three-Arm Trial of Novel Treatment for Tinea Pedis
Sponsor: South End Skin Care
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20258 payments
- UCB, Inc.Program year20253 payments
- Novartis Pharmaceuticals CorporationProgram year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
47.6%Tetracycline-class Drug43.1%Doxycycline Monohydrate100%Part D≥528 patientsFirst-generation cephalosporins4.6%Cephalexin100%Part D≥52 patientsNervous system
26.1%Opioid Agonist26.1%Tramadol Hcl100%Part D≥351 patientsMetabolism & gastrointestinal
21.5%Serotonin-3 Receptor Antagonist21.5%Ondansetron Odt100%Part D≥294 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Chondrocutaneous composite grafts are a viable option for nasal alar defects larger than 1.5 cm
Journal of Plastic Reconstructive & Aesthetic Surgery
2025 - The Impact of Needle Geometry on Tissue Damage and Anastomotic Leakage: A Combined Analysis of Human Skin and Porcine Cardiovascular Models
Journal of Reconstructive Microsurgery
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Lesley Inker, MD
Tufts University
Nadia Waheed, MD
Tufts University
Helen Boucher, MD
Tufts University
Caroline Baumal, MD
Tufts University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”